Intuitive Surgical (ISRG) is a publicly traded Healthcare sector company. As of July 5, 2026, ISRG trades at $426.01 with a market cap of $150.88B and a P/E ratio of 50.96. ISRG moved +5.87% today. Year to date, ISRG is -25.60%; over the trailing twelve months it is -21.20%. Its 52-week range spans $396.68 to $616.00. Analyst consensus is buy with an average price target of $561.33. Rallies surfaces ISRG's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Intuitive Names Taylor Patton Chief Commercial and Marketing Officer, Shifts Henry Charlton to Global Operations SVP: Intuitive will promote Taylor Patton to Chief Commercial and Marketing Officer effective July 1, succeeding Henry Charlton who shifts to Senior Vice President of Global Business Operations. Patton’s two decades at Intuitive include leading the worldwide Ion platform launch across multiple geographies to scale commercial operations.
| Metric | Value |
|---|---|
| Price | $426.01 |
| Market Cap | $150.88B |
| P/E Ratio | 50.96 |
| EPS | $8.36 |
| Dividend Yield | 0.00% |
| 52-Week High | $616.00 |
| 52-Week Low | $396.68 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $10.58B |
| Net Income | $3.00B |
| Gross Margin | 66.29% |
19 analysts cover ISRG: 0 strong buy, 14 buy, 4 hold, 1 sell, 0 strong sell. Consensus rating is buy. Average price target: $561.33.